Therapeutics Related News

CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio

BASEL, Switzerland and CAMBRIDGE, Mass. and DURHAM, N.C., April 17, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer [...]

By | April 18th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intrexon, ZIOPHARM and Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered by Membrane-Bound IL-15 Under RheoSwitch Therapeutic System Control

Germantown, MD, and Boston, MA, April 3, 2017 - Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ZIOPHARM Oncology (NASDAQ: ZIOP), a biopharmaceutical company [...]

By | April 3rd, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other Diseases

SAN FRANCISCO, Calif. – March 15, 2017 – Cell Design Labs, Inc. today announced the issuance of U.S. Patent No. 9,587,020, entitled, “Chimeric Antigen Receptor and Methods of Use Thereof.” This patent, issued to UC San Francisco (UCSF) and exclusively [...]

By | March 26th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

eGenesis Co-Founder Luhan Yang Named Young Global Leader by World Economic Forum

Cambridge, Mass. – March 15, 2017 – Co-founder and chief scientific officer, Luhan Yang, Ph.D., has been honored as a Young Global Leader with the class of 2017. This honor is granted by the World Economic Forum each year to [...]

By | March 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation

Cambridge, Mass., March 16, 2017 — eGenesis, a biotechnology company focused on utilizing genome editing technology to make xenotransplantation a routine and lifesaving medical procedure, today announced that it raised a $38 million Series A financing co-led by Biomatics Capital [...]

By | March 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock

CAMBRIDGE, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of 4,000,000 shares of its common stock at a price to the public of $22.50 [...]

By | March 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|